Literature DB >> 14528079

Tumor dimension and prognosis in surgically treated lung cancer: for intentional limited resection.

Makoto Nonaka1, Mitsutaka Kadokura, Shigeru Yamamoto, Daisuke Kataoka, Toshiaki Kunimura, Miki Kushima, Naoya Horichi, Toshihiro Takaba.   

Abstract

Tumors with a maximum dimension of 3 cm are categorized as T1, whereas those greater than 3 cm are T2 by TNM classification. Some physicians suggest that early-stage peripheral lung cancer should have a maximum tumor diameter of 2 cm and that limited surgery (segmentectomy without lymph node dissection) is acceptable for the patients. In this study, the relationship between the tumor dimension and prognosis was analyzed in 207 patients with surgically treated primary non-small-cell lung cancer (SCLC). The 5-year survival rate of those with tumors 3 cm or less and without lymph node (LN) metastases was 86%, which was significantly higher than that of those with tumors more than 3 cm and without hilar and mediastinal LN metastases (65%) (p < 0.05). However, 33% of the patients with tumors 3 cm or less had LN metastases, and the 5-year survival rate did not differ between those with tumors 3 cm or less (60%) and those with tumors more than 3 cm (54%). Twenty-eight percent of patients with tumors 2 cm or less had LN metastases, and the 5-year survival rate of the patients with tumors 2 cm or less was 62%. The 5-year survival rate of those with tumors 2 cm or less and without LN metastases was 88%. Forty-six patients with tumors 2 cm or less included 5 cases with an intrapulmonary metastasis in the same lobe (11%). In conclusion, a size of 3 cm is an appropriate boundary as the T factor. Because those with tumors 2 cm or less have a relatively high percentage of LN metastases, intraoperative frozen sections of LN should be considered for those undergoing limited surgery for primary non-SCLCs 2 cm or less. Intrapulmonary metastases also should be considered for those undergoing limited surgery even if the maximum dimension of the primary tumor is less than 2 cm.

Entities:  

Mesh:

Year:  2003        PMID: 14528079     DOI: 10.1097/01.coc.0000037739.92442.52

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

Review 1.  Systematic mediastinal lymphadenectomy or mediastinal lymph node sampling in patients with pathological stage I NSCLC: a meta-analysis.

Authors:  Siyuan Dong; Jiang Du; Wenya Li; Shuguang Zhang; Xinwen Zhong; Lin Zhang
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

2.  Clarification of the resection line non-intubated segmentectomy using indocyanine green.

Authors:  Can Vladimir; Kala Zdenek; Frola Lukas; Hudacek Kamil; Kalis Vaclav; Kodytkova Alzbeta; Mitas Ladislav; Moravcik Petr; Rybnickova Sylva; Skrivanova Katerina; Spankova Marketa; Vach Robert; Horvath Teodor
Journal:  Ann Transl Med       Date:  2019-01

3.  A novel technique for identification of the segments based on pulmonary artery plane combined with oxygen diffusing discrepancy.

Authors:  Yandong Zhao; Yunpeng Xuan; Jianfang Song; Tong Qiu; Yi Qin; Wenjie Jiao
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

4.  Novel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue.

Authors:  Shin-Kwang Kang; Jin San Bok; Hyun Jin Cho; Min-Woong Kang
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 5.  Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate.

Authors:  Gail Wan Ying Chua; Kevin Lee Min Chua
Journal:  Thorac Cancer       Date:  2019-08-06       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.